Skip to main content
Skip to footer
Home
About
Franchise
Studies
Contact
Home
About
Franchise
Studies
Contact
Register
Visibility:
Ongoing
Arnasa COPD
12 August 2024
Evaluating novel treatments for chronic obstructive pulmonary disease to enhance breathing and overall lung function.
Pilaster COPD
12 August 2024
Investigating innovative therapies for chronic obstructive pulmonary disease to improve patient outcomes and quality of life.
GERD
12 August 2024
Evaluating new methods to alleviate symptoms of gastroesophageal reflux disease (GERD), a chronic digestive disorder.
Elevate Ulcerative Colititis
12 August 2024
Assessing innovative therapies for ulcerative colitis to improve patient care and disease management.
Incyte 211 Liver
12 August 2024
Evaluating a new treatment approach for hepatocellular cancer, the most common type of primary liver cancer.